Objective: Develop and launch
the corporate brand identity and new product line for AutoGenomics,
a privately held biotech company. AutoGenomics designs, develops, manufactures
and markets fully integrated solutions for genomic and proteomic analyses
incorporating multiple proprietary technologies.
Target Market: The healthcare, forensics and agriculture
industry.
Project
Description: The
agency was retained to conduct market research and recommend a strategic
advertising launch campaign. After a complete analysis, 760 Media determined
the most effective tactical strategy which included the use of direct
mail, brochures and mascot development. The marketing collateral was
then used to launch the company and its products at the American Association
of Clinical Chemistry (AACC) Annual Conference, which was a
huge success.
Result: The campaign brought in over 300 new business
leads and AutoGenomics was approached by two of the largest manufactures
in the market.